Huons Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 2016-05-03
- Employees
- 969
- Market Cap
- -
- Website
- http://www.huons.com
A Phase I Study to Evaluate the Safety and Drug Allergy of Hyaluronidase in Healthy Volunteers
- First Posted Date
- 2024-12-03
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Huons Co., Ltd.
- Target Recruit Count
- 243
- Registration Number
- NCT06713317
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-30
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Huons Co., Ltd.
- Target Recruit Count
- 46
- Registration Number
- NCT06618079
- Locations
- 🇰🇷
Chungbuk national university hospital, Chungbuk, Korea, Republic of
Phase 1 Study in Diabetes Mellitus(Fasting)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-08-13
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Huons Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT06552182
- Locations
- 🇰🇷
Huons, Seoul, Korea, Republic of
Phase 1 Study in Diabetes Mellitus(Fed)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-08-13
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Huons Co., Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT06551740
- Locations
- 🇰🇷
Huons, Seongnam-si, Gyeonggi-do, Korea, Republic of
To Evaluate the Efficacy and Safety of HUC3-053 in Patients With Dry Eye Syndrome
Phase 3
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2024-04-29
- Lead Sponsor
- Huons Co., Ltd.
- Target Recruit Count
- 280
- Registration Number
- NCT06388070
- Locations
- 🇰🇷
Gangbuk Samsung Hospital, Seoul, Jongno-gu, Korea, Republic of
Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops
- First Posted Date
- 2024-02-16
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Huons Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT06263998
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Daehak-ro, Jongno-gu, Korea, Republic of
HU007 in Patients With Dry Eye Syndrome
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-02-24
- Last Posted Date
- 2024-05-13
- Lead Sponsor
- Huons Co., Ltd.
- Target Recruit Count
- 328
- Registration Number
- NCT05743764
- Locations
- 🇰🇷
Gyeongsang National University Hospital, Jinju, Korea, Republic of
Phase 2 of HU-045 in Glabellar Lines
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2023-07-05
- Lead Sponsor
- Huons Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT05298449
- Locations
- 🇰🇷
Chung-Ang University, Seoul, Dongjak-gu, Korea, Republic of
To Evaluate HU-014 in the Treatment of Post Stroke Upper Limb
- First Posted Date
- 2022-03-22
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Huons Co., Ltd.
- Target Recruit Count
- 198
- Registration Number
- NCT05289921
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- Huons Co., Ltd.
- Target Recruit Count
- 13
- Registration Number
- NCT04415346
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath